Don’t miss the latest developments in business and finance.

Aventis Pharma Q3 net rises 57%

BS 200 Scorecard

Image
Our Corporate Bureau Mumbai
Last Updated : Jan 28 2013 | 2:26 AM IST
 Total income (net of excise) during the reporting quarter increased to Rs 168.90 crore, from Rs 162.30 crore in SQ-02.

 

Also Read

First Published: Oct 18 2003 | 12:00 AM IST

Next Story